Company / Financials
Organogenesis Holdings Inc. Financials
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$433.1M
FY2025 · -3.9% YoY
Net Income
$4.9M
FY2025 · -68.2% YoY
Profit Margin
1.1%
FY2025 · net income / revenue
ROE
1.9%
FY2025 · return on equity
Total Assets
$598.7M
FY2025
Total Debt
-
FY2025
Equity
$262.9M
FY2025
ROA
0.8%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$433.1M-3.9% YoYNet Income HistoryProfit after all expenses and taxes$4.9M-68.2% YoYGross Profit HistoryRevenue minus cost of goods sold$345.9M0.0% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$105.0M0.0% YoYOperating Income HistoryProfit from core business operations before interest and taxes$12.5M-43.8% YoYSG&A Expense HistorySelling, general, and administrative expenses$269.8M-5.0% YoYR&D Expense HistoryResearch and development spending$44.4M+11.6% YoYInterest Expense HistoryCost of borrowing and debt obligations$7.2MIncome Tax HistoryTotal income tax expense$5.4M+14.7% YoYEPS (Basic) HistoryBasic earnings per share$0.04-66.7% YoY